Platelet hyper-reactivity in active inflammatory arthritis is unique to the adenosine diphosphate pathway: A novel finding and potential therapeutic target

Rheumatology

Volumn 49, Issue 2, 2010, Pages 240-245

  Mac Mullan, Paul A ^a   Peace, Aaron J ^b   Madigan, Anne M ^a   Tedesco, Anthony F ^b   Kenny, Dermot ^b   McCarthy, Geraldine M ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

Adenosine diphosphate; Inflammatory arthritis; Platelet reactivity

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; ARACHIDONIC ACID; AZATHIOPRINE; C REACTIVE PROTEIN; COLLAGEN; FIBRINOGEN; HYDROXYCHLOROQUINE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; SALAZOSULFAPYRIDINE; STEROID; THROMBIN RECEPTOR ACTIVATING PEPTIDE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOSIS; VISUAL ANALOG SCALE;

ADENOSINE DIPHOSPHATE; ADOLESCENT; ADULT; AGED; ARTHRITIS; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; BLOOD PLATELETS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; SPONDYLITIS, ANKYLOSING; YOUNG ADULT;

EID: 77950407295     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kep377     Document Type: Article

References (20)

1. van Halm VP, Peters MJ, Voskuyl AE et al. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease, a cross sectional study. The Carre investigation. Ann Rheum Dis 2009;68:1395-400.
2. Davi G, Patrono C. Platelet activation and atherothrom-bosis. N Engl J Med 2007;357:2482-94.
3. Naranjo A, Sokka T, Descalzo MA et al. Cardiovascular disease in patients with rheumatoid arthritis: results from the quest-RA study. Arthritis Res Ther 2008;10:R30.
4. Barrett NE, Holbrook L, Jones S et al. Future innovations in anti-platelet therapies. Br J Pharmacol 2008;154: 918-39.
5. Riddle JM, Bluhm GB, Pitchford WC et al. A comparative study of platelet reactivity in arthritis. Ann N Y Acad Sci 1981;370:22-9.
6. Wang F, Wang NS, Yan CG, Li JH, Tang LQ. The significance of platelet activation in rheumatoid arthritis. Clin Rheumatol 2007;26:768-71.
7. Harrison P, Keeling D. Platelet hyperactivity and risk of recurrent thrombosis. J Thromb Haemost 2006;4: 2544-6.
8. Angiolillo DJ, Bernardo E, Sabate M et al. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol 2007;50:1541-7.
9. Gurbel PA, Becker RC, Mann KG, Steinhubl SR, Michelson AD. Platelet function monitoring in patients with coronary artery disease. J Am Coll Cardiol 2007;50: 1822-34.
10. Peace AJ, Tedesco AF, Foley DP, Dicker P, Berndt MC, Kenny D. Dual antiplatelet therapy unmasks distinct platelet reactivity in patients with coronary artery disease. J Thromb Haemost 2009;7:363-4.
11. Smolen JS, Breedveld FC, Eberl G et al. Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity. Arthritis Rheum 1995; 38:38-43.
12. Patrono C, Coller B, FitzGerald GA, Hirsh J, Roth G. Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on antithrombotic and thrombolytic therapy. Chest 2004;126:234S-64S.
13. Mani H, Luxembourg B, Klaffling C, Erbe M, Lindhoff-Last E. Use of native or platelet count adjusted platelet rich plasma for platelet aggregation measurements. J Clin Pathol 2005;58:747-50.
14. Winocour PD, Perry DW, Kinlough-Rathbone RL. Hypersensitivity to ADP of platelets from diabetic rats associated with enhanced fibrinogen binding. Eur J Clin Invest 1992;22:19-23.
15. Ang L, Palakodeti V, Khalid A et al. Elevated plasma fibrinogen and diabetes mellitus are associated with lower inhibition of platelet reactivity with clopidogrel. J Am Coll Cardiol 2008;52:1052-9.
16. Dessein PH, Joffe BI. Insulin resistance and impaired beta cell function in rheumatoid arthritis. Arthritis Rheum 2006; 54:2765-75.
17. Gonzalez-Gay MA, De Matias JM, Gonzalez-Juanatey C et al. Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis. Clin Exp Rheumatol 2006;24:83-6.
18. Schneider DJ. Abnormalities of coagulation, platelet function, and fibrinolysis associated with syndromes of insulin resistance. Coron Artery Dis 2005;16:473-6.
19. Hermann A, Rauch BH, Braun M, Schror K, Weber AA. Platelet CD40 ligand (CD40L)-subcellular localization, regulation of expression, and inhibition by clopidogrel. Platelets 2001;12:74-82.
20. Pignatelli P, Cangemi R, Celestini A et al. Tumour necrosis factor alpha upregulates platelet CD40L in patients with heart failure. Cardiovasc Res 2008;78: 515-22.